M Mahmood Hussain Selected Research

O(4)-methylthymidine triphosphate

12/2020	Membrane-bound sn-1,2-diacylglycerols explain the dissociation of hepatic insulin resistance from hepatic steatosis in MTTP knockout mice.
1/2019	Normal serum ApoB48 and red cells vitamin E concentrations after supplementation in a novel compound heterozygous case of abetalipoproteinemia.
1/2017	Lack of MTTP Activity in Pluripotent Stem Cell-Derived Hepatocytes and Cardiomyocytes Abolishes apoB Secretion and Increases Cell Stress.
1/2016	Mice subjected to aP2-Cre mediated ablation of microsomal triglyceride transfer protein are resistant to high fat diet induced obesity.
2/2012	Multiple functions of microsomal triglyceride transfer protein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Mahmood Hussain Research Topics

Disease

23	Atherosclerosis 01/2022 - 11/2002
11	Hyperlipidemias (Hyperlipidemia) 01/2022 - 05/2008
10	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 12/2002
9	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 09/2005
9	Insulin Resistance 12/2020 - 05/2006
8	Abetalipoproteinemia (Bassen Kornzweig Syndrome) 01/2019 - 06/2006
6	Obesity 01/2017 - 09/2005
5	Hypercholesterolemia 01/2018 - 06/2009
4	Non-alcoholic Fatty Liver Disease 12/2020 - 07/2016
4	Fatty Liver 01/2020 - 05/2006
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 09/2010
3	Metabolic Diseases (Metabolic Disease) 01/2022 - 06/2011
3	Type 2 Diabetes Mellitus (MODY) 01/2019 - 09/2005
3	Heart Diseases (Heart Disease) 01/2018 - 10/2002
3	Body Weight (Weight, Body) 01/2016 - 07/2007
3	Thrombosis (Thrombus) 03/2005 - 04/2002
2	Dyslipidemias (Dyslipidemia) 01/2020 - 01/2019
2	Fibrosis (Cirrhosis) 01/2020 - 06/2007
2	Liver Diseases (Liver Disease) 01/2020 - 07/2014
2	Atherosclerotic Plaque (Atheroma) 01/2017 - 06/2012
2	Infections 01/2016 - 07/2012
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2014 - 06/2011
2	Carcinoma (Carcinomatosis) 09/2007 - 06/2007
1	Hemangioma (Angioma) 01/2021
1	Xanthomatosis (Xanthoma) 01/2021
1	Glucose Intolerance 12/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Disease Progression 01/2019
1	Homozygous Familial Hypercholesterolemia 01/2017
1	Cardiomyopathies (Cardiomyopathy) 01/2017
1	Hypobetalipoproteinemias (Hypobetalipoproteinemia) 11/2016
1	Autoimmune Diseases (Autoimmune Disease) 07/2015
1	Proteinuria 01/2015
1	Chronic Renal Insufficiency 01/2015
1	Hypertriglyceridemia 11/2014

Drug/Important Bio-Agent (IBA)

24	LipidsIBA 01/2022 - 10/2002
19	Lipoproteins (Lipoprotein)IBA 01/2022 - 06/2007
14	microsomal triglyceride transfer proteinIBA 12/2020 - 05/2006
12	Triglycerides (Triacylglycerol)IBA 01/2022 - 06/2007
11	Apolipoproteins B (ApoB)IBA 01/2020 - 06/2007
11	CholesterolIBA 01/2018 - 09/2007
10	Apolipoproteins E (ApoE)IBA 01/2020 - 04/2009
8	ApolipoproteinsIBA 01/2022 - 09/2007
8	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2002
6	ChylomicronsIBA 01/2022 - 05/2008
6	Pharmaceutical PreparationsIBA 01/2020 - 04/2002
5	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2022 - 02/2006
5	O(4)-methylthymidine triphosphateIBA 12/2020 - 02/2012
4	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 12/2002
4	LDL Lipoproteins (beta Lipoproteins)IBA 01/2017 - 09/2010
4	Messenger RNA (mRNA)IBA 07/2013 - 05/2006
3	Vitamin E FDA LinkGeneric 01/2019 - 06/2006
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 05/2012
3	EnzymesIBA 01/2017 - 06/2012
2	Biological ProductsIBA 01/2022 - 01/2019
2	Insulin (Novolin)FDA Link 12/2020 - 05/2006
2	CeramidesIBA 12/2020 - 10/2015
2	Apolipoprotein B-48IBA 01/2020 - 01/2019
2	oxidized low density lipoproteinIBA 01/2020 - 01/2017
2	RNA (Ribonucleic Acid)IBA 01/2019 - 05/2006
2	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2018
2	LDL CholesterolIBA 01/2017 - 09/2010
2	VLDL LipoproteinsIBA 01/2017 - 07/2007
2	SphingolipidsIBA 01/2017 - 10/2015
2	HDL LipoproteinsIBA 01/2016 - 01/2015
2	SphingomyelinsIBA 10/2015 - 04/2009
2	Inositol (Myoinositol)IBA 08/2013 - 06/2012
2	HDL CholesterolIBA 08/2011 - 04/2006
2	CytokinesIBA 03/2005 - 11/2002
1	Aryl Hydrocarbon Receptor Nuclear TranslocatorIBA 01/2022
1	apolipoprotein A-IV (apolipoprotein AIV)IBA 01/2022
1	EmulsionsIBA 01/2022
1	Liposomes (Liposome)IBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 12/2020
1	Insulin ReceptorIBA 12/2020
1	LipopolysaccharidesIBA 01/2020
1	mouse MIRN29 microRNAIBA 01/2019
1	Blood Glucose (Blood Sugar)IBA 01/2019
1	locked nucleic acidIBA 01/2019
1	Transaminases (Aminotransferases)IBA 01/2018
1	Coenzyme A Ligases (Acid-Thiol Ligases)IBA 01/2017
1	BMS201038IBA 01/2017
1	FructoseIBA 07/2016
1	Bile Acids and Salts (Bile Acids)IBA 01/2016
1	CarbonIBA 01/2016
1	LDL Receptors (LDL Receptor)IBA 01/2016
1	Liver X ReceptorsIBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	CDw17 antigen (lactosylceramide)IBA 10/2015
1	Protein Disulfide-IsomerasesIBA 10/2015
1	Immunoglobulin G (IgG)IBA 07/2015
1	SS-A antigen (Ro antigen)IBA 07/2015
1	Prednisone (Sone)FDA LinkGeneric 01/2015
1	HIV Protease InhibitorsIBA 01/2015
1	CreatinineIBA 01/2015
1	Cytosolic acetoacetyl-CoA thiolase deficiencyIBA 11/2014

Therapy/Procedure

5	Therapeutics 01/2017 - 03/2010
1	Glycemic Control 01/2019
1	Parenteral Nutrition 07/2014